logo
explain how to read the page

The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 5
  • 1
    Rabin, Joel Stewart
    Born in February 1974
    Individual (10 offsprings)
    Officer
    icon of calendar 2009-01-23 ~ now
    OF - Director → CIF 0
  • 2
    Glanvill, Sheryl Anne
    Born in November 1970
    Individual (3 offsprings)
    Officer
    icon of calendar 2015-09-07 ~ now
    OF - Director → CIF 0
  • 3
    Barry, Christian
    Born in January 1976
    Individual (13 offsprings)
    Officer
    icon of calendar 2015-08-12 ~ now
    OF - Director → CIF 0
  • 4
    Rabin, Fabienne
    Individual (7 offsprings)
    Officer
    icon of calendar 2009-01-23 ~ now
    OF - Secretary → CIF 0
  • 5
    icon of addressOld Station Road, Loughton, Essex, United Kingdom
    Active Corporate (3 parents, 2 offsprings)
    Equity (Company account)
    7,079,138 GBP2024-06-30
    Person with significant control
    icon of calendar 2019-05-22 ~ now
    PE - Ownership of shares – 75% or more → CIF 0
    PE - Ownership of voting rights - 75% or more → CIF 0
    PE - Right to appoint or remove directors → CIF 0
Ceased 4
  • 1
    Mr Joel Rabin
    Born in February 1974
    Individual (10 offsprings)
    Person with significant control
    icon of calendar 2016-04-06 ~ 2019-05-21
    PE - Ownership of shares – More than 25% but not more than 50% → CIF 0
    PE - Ownership of voting rights - More than 25% but not more than 50% → CIF 0
  • 2
    Jakobsen, David Lars
    Director born in December 1958
    Individual (2 offsprings)
    Officer
    icon of calendar 2015-08-12 ~ 2023-12-02
    OF - Director → CIF 0
  • 3
    Mr Barry Christian
    Born in January 1976
    Individual (13 offsprings)
    Person with significant control
    icon of calendar 2016-04-06 ~ 2019-05-22
    PE - Ownership of voting rights - More than 25% but not more than 50% → CIF 0
    PE - Ownership of shares – More than 25% but not more than 50% → CIF 0
  • 4
    White, Christina
    Finance Director born in August 1967
    Individual (1 offspring)
    Officer
    icon of calendar 2016-08-22 ~ 2020-01-31
    OF - Director → CIF 0
parent relation
Company in focus

TELETA PHARMA LIMITED

Previous name
PHABS PHARMA LIMITED - 2015-08-26
Standard Industrial Classification
46460 - Wholesale Of Pharmaceutical Goods
Brief company account
Average Number of Employees
402023-07-01 ~ 2024-06-30
422022-07-01 ~ 2023-06-30
Turnover/Revenue
13,997,034 GBP2023-07-01 ~ 2024-06-30
16,451,096 GBP2022-07-01 ~ 2023-06-30
Cost of Sales
-11,429,905 GBP2023-07-01 ~ 2024-06-30
-13,587,927 GBP2022-07-01 ~ 2023-06-30
Gross Profit/Loss
2,567,129 GBP2023-07-01 ~ 2024-06-30
2,863,169 GBP2022-07-01 ~ 2023-06-30
Administrative Expenses
-1,928,870 GBP2023-07-01 ~ 2024-06-30
-1,959,652 GBP2022-07-01 ~ 2023-06-30
Operating Profit/Loss
667,272 GBP2023-07-01 ~ 2024-06-30
903,517 GBP2022-07-01 ~ 2023-06-30
Other Interest Receivable/Similar Income (Finance Income)
89,250 GBP2023-07-01 ~ 2024-06-30
Profit/Loss on Ordinary Activities Before Tax
756,522 GBP2023-07-01 ~ 2024-06-30
903,517 GBP2022-07-01 ~ 2023-06-30
Profit/Loss
638,270 GBP2023-07-01 ~ 2024-06-30
751,453 GBP2022-07-01 ~ 2023-06-30
Property, Plant & Equipment
131,416 GBP2024-06-30
166,094 GBP2023-06-30
Fixed Assets - Investments
45 GBP2023-06-30
Fixed Assets
131,416 GBP2024-06-30
166,139 GBP2023-06-30
Total Inventories
1,386,950 GBP2024-06-30
1,418,855 GBP2023-06-30
Debtors
Current
7,792,224 GBP2024-06-30
6,106,935 GBP2023-06-30
Cash at bank and in hand
640,685 GBP2024-06-30
1,858,444 GBP2023-06-30
Current Assets
9,819,859 GBP2024-06-30
9,384,234 GBP2023-06-30
Creditors
Current, Amounts falling due within one year
-6,029,126 GBP2024-06-30
-6,257,825 GBP2023-06-30
Net Current Assets/Liabilities
3,790,733 GBP2024-06-30
3,126,409 GBP2023-06-30
Total Assets Less Current Liabilities
3,922,149 GBP2024-06-30
3,292,548 GBP2023-06-30
Net Assets/Liabilities
3,889,295 GBP2024-06-30
3,251,025 GBP2023-06-30
Equity
Called up share capital
100 GBP2024-06-30
100 GBP2023-06-30
100 GBP2022-07-01
Retained earnings (accumulated losses)
3,889,195 GBP2024-06-30
3,250,925 GBP2023-06-30
2,499,472 GBP2022-07-01
Equity
3,889,295 GBP2024-06-30
3,251,025 GBP2023-06-30
2,499,572 GBP2022-07-01
Profit/Loss
Retained earnings (accumulated losses)
638,270 GBP2023-07-01 ~ 2024-06-30
751,453 GBP2022-07-01 ~ 2023-06-30
Comprehensive Income/Expense
Retained earnings (accumulated losses)
638,270 GBP2023-07-01 ~ 2024-06-30
751,453 GBP2022-07-01 ~ 2023-06-30
Comprehensive Income/Expense
638,270 GBP2023-07-01 ~ 2024-06-30
751,453 GBP2022-07-01 ~ 2023-06-30
Audit Fees/Expenses
12,115 GBP2023-07-01 ~ 2024-06-30
11,648 GBP2022-07-01 ~ 2023-06-30
Wages/Salaries
1,141,953 GBP2023-07-01 ~ 2024-06-30
1,164,193 GBP2022-07-01 ~ 2023-06-30
Social Security Costs
124,674 GBP2023-07-01 ~ 2024-06-30
128,703 GBP2022-07-01 ~ 2023-06-30
Staff Costs/Employee Benefits Expense
1,290,347 GBP2023-07-01 ~ 2024-06-30
1,316,031 GBP2022-07-01 ~ 2023-06-30
Director Remuneration
203,597 GBP2023-07-01 ~ 2024-06-30
260,664 GBP2022-07-01 ~ 2023-06-30
Deferred Tax Expense/Credit Relating to Origination/Reversal Timing Differences
-8,669 GBP2023-07-01 ~ 2024-06-30
-9,669 GBP2022-07-01 ~ 2023-06-30
Tax Expense/Credit at Applicable Tax Rate
189,131 GBP2023-07-01 ~ 2024-06-30
185,221 GBP2022-07-01 ~ 2023-06-30
Property, Plant & Equipment - Gross Cost
Motor vehicles
110,050 GBP2024-06-30
110,050 GBP2023-06-30
Furniture and fittings
143,023 GBP2024-06-30
140,723 GBP2023-06-30
Computers
44,524 GBP2024-06-30
42,745 GBP2023-06-30
Property, Plant & Equipment - Gross Cost
297,597 GBP2024-06-30
293,518 GBP2023-06-30
Property, Plant & Equipment - Accumulated Depreciation (Not Including Impairment)
Motor vehicles
26,700 GBP2023-06-30
Furniture and fittings
68,156 GBP2023-06-30
Computers
32,568 GBP2023-06-30
Property, Plant & Equipment - Accumulated Depreciation (Not Including Impairment)
127,424 GBP2023-06-30
Property, Plant & Equipment - Increase From Depreciation Charge for Year
Motor vehicles, Owned/Freehold
13,350 GBP2023-07-01 ~ 2024-06-30
Owned/Freehold
38,757 GBP2023-07-01 ~ 2024-06-30
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Motor vehicles
40,050 GBP2024-06-30
Furniture and fittings
86,717 GBP2024-06-30
Computers
39,414 GBP2024-06-30
Property, Plant & Equipment - Accumulated Depreciation & Impairment
166,181 GBP2024-06-30
Property, Plant & Equipment
Motor vehicles
70,000 GBP2024-06-30
83,350 GBP2023-06-30
Furniture and fittings
56,306 GBP2024-06-30
72,567 GBP2023-06-30
Computers
5,110 GBP2024-06-30
10,177 GBP2023-06-30
Finished Goods/Goods for Resale
1,386,950 GBP2024-06-30
1,418,855 GBP2023-06-30
Trade Debtors/Trade Receivables
Current
1,112,284 GBP2024-06-30
1,689,737 GBP2023-06-30
Other Debtors
Current
6,033,318 GBP2024-06-30
3,806,151 GBP2023-06-30
Prepayments/Accrued Income
Current
646,622 GBP2024-06-30
550,217 GBP2023-06-30
Cash and Cash Equivalents
640,685 GBP2024-06-30
1,858,444 GBP2023-06-30
Trade Creditors/Trade Payables
Current
819,695 GBP2024-06-30
1,288,319 GBP2023-06-30
Amounts owed to group undertakings
Current
4,903,953 GBP2024-06-30
4,474,121 GBP2023-06-30
Corporation Tax Payable
Current
126,922 GBP2024-06-30
161,733 GBP2023-06-30
Taxation/Social Security Payable
Current
35,971 GBP2024-06-30
234,303 GBP2023-06-30
Other Creditors
Current
45,337 GBP2024-06-30
31,390 GBP2023-06-30
Accrued Liabilities/Deferred Income
Current
97,248 GBP2024-06-30
67,959 GBP2023-06-30
Creditors
Current
6,029,126 GBP2024-06-30
6,257,825 GBP2023-06-30
Net Deferred Tax Liability/Asset
-32,854 GBP2024-06-30
-41,523 GBP2023-06-30
Profit/Loss - Increase/Decrease in Net Deferred Tax Liability from Amount Recognised
8,669 GBP2023-07-01 ~ 2024-06-30
Deferred Tax Liabilities
Accelerated tax depreciation
-32,854 GBP2024-06-30
-41,523 GBP2023-06-30
Number of Shares Issued (Fully Paid)
Class 1 ordinary share
100 shares2024-06-30
100 shares2023-06-30
Par Value of Share
Class 1 ordinary share
1.002023-07-01 ~ 2024-06-30
Future Minimum Lease Payments Under Non-cancellable Operating Leases
Amounts falling due within one year
19,445 GBP2024-06-30
114,679 GBP2023-06-30
Between one and five year
47,120 GBP2023-06-30
Future Minimum Lease Payments Under Non-cancellable Operating Leases
19,445 GBP2024-06-30
161,799 GBP2023-06-30
Related profiles found in government register
  • TELETA PHARMA LIMITED
    Info
    PHABS PHARMA LIMITED - 2015-08-26
    Registered number 06800217
    icon of addressC/o Haslers, Old Station Road, Loughton, Essex IG10 4PL
    PRIVATE LIMITED COMPANY incorporated on 2009-01-23 (16 years 10 months). The company status is Active.
    The last date of confirmation statement was made at 2025-05-24
    CIF 0
  • TELETA PHARMA LTD
    S
    Registered number 06800217
    icon of addressC/o Haslers, Old Station Road, Loughton, Essex, United Kingdom, IG10 4PL
    Private Company Limited By Shares in Uk Register Of Companies, United Kingdom
    CIF 1
child relation
Offspring entities and appointments
Active 1
  • icon of address25 Sandyford Place, Glasgow, Scotland
    Active Corporate (5 parents)
    Equity (Company account)
    100 GBP2024-06-30
    Person with significant control
    icon of calendar 2022-06-13 ~ now
    CIF 1 - Ownership of shares – More than 25% but not more than 50% → OE
    CIF 1 - Ownership of voting rights - More than 25% but not more than 50% → OE

qrcode

Privacy notice

Terms and conditions

The content of this website is protected by AgonGuard.

© 2022-2025 Polylogarithmic Technology Ltd (Registered in England and Wales No. 14256313). All rights reserved.

Contains public sector information retrieved at 12 November 2025 and licensed under the Open Government Licence v3.0.